{"id":89262,"date":"2016-11-22T12:27:02","date_gmt":"2016-11-22T12:27:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=89262"},"modified":"2016-11-22T12:27:02","modified_gmt":"2016-11-22T12:27:02","slug":"global-cord-stem-cell-banking-market-will-be-worth-usd-63-billion-by-2022-new-market-reports-by-data-bridge-market-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-cord-stem-cell-banking-market-will-be-worth-usd-63-billion-by-2022-new-market-reports-by-data-bridge-market-research_89262.html","title":{"rendered":"Global Cord Stem Cell Banking Market will be worth USD 6.3 billion by 2022 – New market reports by Data Bridge Market Research"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Global Cord Stem Cell Banking Market is expected to grow at 22.4% in the forecast period 2016 to 2022”<\/div>\n<\/div>\n<\/div>\n
Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) \u2013 Trends and Forecast to 2022<\/div>\n

Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022<\/strong><\/p>\n

Global Cord Stem Cell Banking Market is expected to reach USD 6.3 billion by 2022, from USD 1.5 billion in 2015 growing at a CAGR of 22.4% during the forecast period of 2016 to 2022.<\/p>\n

Global Cord Stem Cell Banking market has been segmented and analyzed on the basis of storage, services, product type, source, indication, and geography.<\/p>\n

For Sample Report: <\/strong>http:\/\/databridgemarketresearch.com\/reports\/global-cord-stem-cell-banking-market-trends-forecast-2022\/<\/a><\/p>\n

Based on product type, the market has been segmented into Cord Blood, Cord Blood & Cord Tissue.<\/p>\n

On the basis of storage, the cord stem cell banking market is segmented into Public Banking and Private Banking.<\/p>\n

On the basis of service type the market is segmented into Collection & Transportation, Processing, Analysis, and Storage.<\/p>\n

\"\"<\/strong><\/p>\n

 <\/p>\n

To read more about the scope and findings of this report visit:<\/strong> http:\/\/databridgemarketresearch.com\/cord-stem-cell-banking-market-usd-6-3\/<\/a><\/p>\n

On the basis of source the market is segmented into Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, and Menstrual Blood.<\/p>\n

Based on indication the market is further segmented into Cerebral Palsy, Thalassemia, Leukemia, Diabetes, and Autism.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

Based on geography, the market report covers data for 5 geographical regions namely North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa. The report includes market shares of intra-uterine devices market for global, North America, Europe and Asia Pacific.<\/p>\n

Key players operating in this market are players operating in this market are CBR Systems, Inc., Cordlife, CryoCell, Cryo-Save AG, Lifecell, Stemcyte, Viacord, Smart Cells International, Ltd., Cryoviva India and China Cord Blood Corporation among others.<\/p>\n

To Browse Full Report and Pricing:<\/strong> http:\/\/databridgemarketresearch.com\/reports\/global-cord-stem-cell-banking-market-trends-forecast-2022\/<\/a><\/p>\n

 <\/p>\n

Table of Contents:<\/strong><\/p>\n

1. INTRODUCTION<\/strong><\/p>\n

    1.1. OVERVIEW OF THE CORD STEM CELL BANKING MARKET<\/p>\n

    1.2. MARKET SEGMENTATION & COVERAGE<\/p>\n

          1.2.1. CURRENCY AND PRICING <\/p>\n

          1.2.2. LIMITATION<\/p>\n

2. RESEARCH METHODOLOGY<\/strong><\/p>\n

    2.1. KEY TAKEAWAYS<\/p>\n

    2.2. ARRIVING AT THE CORD STEM CELL BANKING MARKET SIZE<\/p>\n

          2.2.1. MARKET CRACKDOWN APPROACH <\/p>\n

          2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS<\/p>\n

          2.2.3. DATA TRIANGULATION<\/p>\n

          2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES<\/p>\n

          2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES<\/p>\n

          2.2.6. PORTER’S FIVE FORCES MATRIX<\/p>\n

          2.2.7. PEST ANALYSIS<\/p>\n

    2.4. GLOBAL CORD STEM CELL BANKING MARKET: RESEARCH SNAPSHOT<\/p>\n

    2.3. ASSUMPTIONS<\/p>\n

3. MARKET LANDSCAPE SUMMARY<\/strong><\/p>\n

4. PREMIUM INSIGHTS<\/strong><\/p>\n

    4.1. OVERVIEW<\/p>\n

    4.2. CORD STEM CELL BANKING MARKET: KEY PRIMARY INSIGHTS<\/p>\n

    4.3. MARKET OVERVIEW<\/p>\n

          4.3.1. DRIVERS<\/p>\n

                   4.3.1.1. EASY EXTRACTION METHODS<\/p>\n

                   4.3.1.2. RISING NUMBER OF NEWBORNS<\/p>\n

                   4.3.1.3. INCREASED ACCEPTANCE OF STEM CELL THERAPEUTICS<\/p>\n

                   4.3.1.4. NEW APPLICATIONS OF STEM CELLS IN DISEASE TREATMENT<\/p>\n

          4.3.2. RESTRAINTS<\/p>\n

                   4.3.2.1. LACK OF AWARENESS IN MANY DEVELOPING ECONOMIES<\/p>\n

                   4.3.2.2. CONSTRAINING LEGAL AND HEALTHCARE REGULATIONS<\/p>\n

                   4.3.2.3. HIGH OPERATING COST OF STEM CELL THERAPEUTICS<\/p>\n

          4.3.3. OPPURTUNITIES <\/p>\n

                   4.3.2.1. RISING AWARENESS ABOUT USAGE OF CORD TISSUE<\/p>\n

                   4.3.2.2. CORD BLOOD BANKS COLLABORATIONS<\/p>\n

                   4.3.2.3. INCREASED TECHNOLOGICAL DEVELOPEMENT<\/p>\n

          4.3.4. THREATS<\/p>\n

    4.4. KEY MARKET FINDINGS<\/p>\n

    4.5. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES<\/p>\n

5. CORD STEM CELL BANKING MARKET, BY STORAGE TYPE<\/strong><\/p>\n

    5.1. OVERVIEW<\/p>\n

    5.2. PUBLIC CORD STEM CELL BANKING<\/p>\n

          5.2.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          5.2.2. NUMBER OF UNITS STORED, 2014 TO 2022<\/p>\n

          5.2.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    5.3. PRIVATE CORD STEM CELL BANKING<\/p>\n

          5.3.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          5.3.2. NUMBER OF UNITS STORED, 2014 TO 2022<\/p>\n

          5.3.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    5.4. COMPARISON MATRIX: PUBLIC VS PRIVATE CORD STEM CELL BANKING<\/p>\n

6. CORD STEM CELL BANKING MARKET, BY PRODUCT TYPE<\/strong><\/p>\n

    6.1. OVERVIEW<\/p>\n

    6.2. CORD BLOOD<\/p>\n

          6.2.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          6.2.2. NUMBER OF UNITS STORED, 2014 TO 2022<\/p>\n

          6.2.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    6.3. CORD TISSUE AND CORD BLOOD<\/p>\n

          6.3.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          6.3.2. NUMBER OF UNITS STORED, 2014 TO 2022<\/p>\n

          6.3.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

7. CORD STEM CELL BANKING MARKET, BY SERVICE TYPE<\/strong><\/p>\n

    7.1. OVERVIEW<\/p>\n

    7.2. COLLECTION & TRANSPORTATION<\/p>\n

    7.3. ANALYSIS<\/p>\n

    7.4. PROCESSING <\/p>\n

    7.5. STORAGE<\/p>\n

8. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE<\/strong><\/p>\n

    8.1. OVERVIEW<\/p>\n

    8.2. UMBILICAL CORD BLOOD<\/p>\n

    8.3. BONE MARROW<\/p>\n

    8.4. PERIPHERAL BLOOD STEM <\/p>\n

    8.5. MENSTRUAL BLOOD<\/p>\n

9. CORD STEM CELL BANKING MARKET, BY SOURCE TYPE<\/strong><\/p>\n

    9.1. OVERVIEW<\/p>\n

    9.2. CEREBRAL PALSY<\/p>\n

          9.2.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          9.2.2. NUMBER OF UNITS USED, 2014 TO 2022<\/p>\n

          9.2.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    9.3. THALASSEMIA<\/p>\n

          9.3.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          9.3.2. NUMBER OF UNITS USED, 2014 TO 2022<\/p>\n

          9.3.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    9.4. LEUKEMIA <\/p>\n

          9.4.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          9.4.2. NUMBER OF UNITS USED, 2014 TO 2022<\/p>\n

          9.4.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    9.5. DIABETES<\/p>\n

          9.5.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          9.5.2. NUMBER OF UNITS USED, 2014 TO 2022<\/p>\n

          9.5.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    9.6. AUTISM<\/p>\n

          9.6.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          9.6.2. NUMBER OF UNITS USED, 2014 TO 2022<\/p>\n

          9.6.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

    9.7. OTHERS<\/p>\n

          9.7.1. MARKET VALUE, 2014 TO 2022<\/p>\n

          9.7.2. NUMBER OF UNITS USED, 2014 TO 2022<\/p>\n

          9.7.3. MARKET TRENDS AND FORECAST INSIGHTS<\/p>\n

10. CORD STEM CELL BANKING MARKET, BY GEOGRAPHY<\/strong><\/p>\n

      10.1. COUNTRYWISE CORD STEM CELL BANKING MARKET, (VALUE AND VOLUME)                                                                  (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)<\/p>\n

              10.1.1. NORTH AMERICA<\/p>\n

                        10.1.1.1. U.S.<\/p>\n

                        10.1.1.2. CANADA<\/p>\n

                        10.1.1.3. MEXICO<\/p>\n

              10.1.2. EUROPE<\/p>\n

                        10.1.2.1. GERMANY<\/p>\n

                        10.1.2.2. FRANCE<\/p>\n

                        10.1.2.3. U.K.<\/p>\n

                        10.1.2.4. ITALY<\/p>\n

                        10.1.2.5. SPAIN<\/p>\n

                        10.1.2.6. RUSSIA<\/p>\n

                        10.1.2.7. TURKEY<\/p>\n

                        10.1.2.8. BELGIUM<\/p>\n

                        10.1.2.9. NETHERLANDS<\/p>\n

                        10.1.2.10. SWITZERLAND<\/p>\n

                        10.1.2.11. REST OF EUROPE<\/p>\n

              10.1.3. ASIA-PACIFIC (APAC)<\/p>\n

                        10.1.3.1. JAPAN<\/p>\n

                        10.1.3.2. CHINA<\/p>\n

                        10.1.3.3. SOUTH KOREA<\/p>\n

                        10.1.3.4. INDIA<\/p>\n

                        10.1.3.5. AUSTRALIA<\/p>\n

                        10.1.3.6. SINGAPORE<\/p>\n

                        10.1.3.7. THAILAND<\/p>\n

                        10.1.3.8. MALAYSIA<\/p>\n

                        10.1.3.9. INDONESIA<\/p>\n

                        10.1.3.10. PHILIPPINES<\/p>\n

                        10.1.3.11. REST OF APAC<\/p>\n

              10.1.4. LATIN AMERICA<\/p>\n

                        10.1.4.1. BRAZIL<\/p>\n

                        10.1.4.2. REST OF LATIN AMERICA<\/p>\n

              10.1.5. MIDDLE EAST AND AFRICA<\/p>\n

                        10.1.5.1. SOUTH AFRICA<\/p>\n

                        10.1.5.2. REST OF MIDDLE EAST AND AFRICA<\/p>\n

      10.2.      KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES<\/p>\n

11      CORD STEM CELL BANKING MARKET: COMPETITIVE LANDSCAPE<\/strong><\/p>\n

      11.1.      GLOBAL CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS<\/p>\n

      11.2.      NORTH AMERICA CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS<\/p>\n

      11.3.      EUROPE CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS<\/p>\n

      11.4.      APAC CORD STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS<\/p>\n

      11.5.      MERGERS & ACQUISITIONS<\/p>\n

      11.6.      NEW PRODUCT DEVELOPMENT & APPROVALS<\/p>\n

      11.7.      EXPANSIONS<\/p>\n

      11.8.      REGULATORY CHANGES<\/p>\n

      11.9.      PATENTS<\/p>\n

      11.10.     PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS<\/p>\n

12      CORD STEM CELL BANKING MARKET, COMPANY PROFILES <\/strong><\/p>\n

      12.1       CBR SYSTEMS, INC.<\/p>\n

              12.1.1  OVERVIEW<\/p>\n

              12.1.2  SWOT ANALYSIS<\/p>\n

              12.1.3  PRODUCT PORTFOLIO<\/p>\n

              12.1.4  REVENUE ANALYSIS<\/p>\n

              12.1.5  ANALYSTS VIEW<\/p>\n

      12.2       CORDLIFE<\/p>\n

              12.2.1   OVERVIEW<\/p>\n

              12.2.2   SWOT ANALYSIS<\/p>\n

              12.2.3   PRODUCT PORTFOLIO<\/p>\n

              12.2.4   REVENUE ANALYSIS<\/p>\n

              12.2.5   ANALYSTS VIEW<\/p>\n

      12.3       CRYOCELL<\/p>\n

              12.3.1   OVERVIEW<\/p>\n

              12.3.2   SWOT ANALYSIS<\/p>\n

              12.3.3   PRODUCT PORTFOLIO<\/p>\n

              12.3.4   REVENUE ANALYSIS<\/p>\n

              12.3.5   ANALYST VIEW<\/p>\n

      12.4       CRYO-SAVE AG<\/p>\n

              12.4.1   OVERVIEW<\/p>\n

              12.4.2   SWOT ANALYSIS<\/p>\n

              12.4.3   PRODUCT PORTFOLIO<\/p>\n

              12.4.4   REVENUE ANALYSIS<\/p>\n

              12.4.5   ANALYSTS VIEW<\/p>\n

      12.5       LIFECELL<\/p>\n

              12.5.1   OVERVIEW<\/p>\n

              12.5.2   SWOT ANALYSIS<\/p>\n

              12.5.3   PRODUCT PORTFOLIO<\/p>\n

              12.5.4   REVENUE ANALYSIS<\/p>\n

              12.5.5   ANALYSTS VIEW<\/p>\n

      12.6       STEMCYTE<\/p>\n

              12.6.1   OVERVIEW<\/p>\n

              12.6.2   SWOT ANALYSIS<\/p>\n

              12.6.3   PRODUCT PORTFOLIO<\/p>\n

              12.6.4   REVENUE ANALYSIS<\/p>\n

              12.6.5   ANALYSTS VIEW<\/p>\n

      12.7       SMART CELLS INTERNATIONAL, LTD.<\/p>\n

              12.7.1   OVERVIEW<\/p>\n

              12.7.2   SWOT ANALYSIS<\/p>\n

              12.7.3   PRODUCT PORTFOLIO<\/p>\n

              12.7.4   REVENUE ANALYSIS<\/p>\n

              12.7.5   ANALYSTS VIEW<\/p>\n

      12.8       CRYOVIVA INDIA<\/p>\n

              12.8.1   OVERVIEW<\/p>\n

              12.8.2   SWOT ANALYSIS<\/p>\n

              12.8.3   PRODUCT PORTFOLIO<\/p>\n

              12.8.4   REVENUE ANALYSIS<\/p>\n

              12.8.5   ANALYSTS VIEW<\/p>\n

      12.9       CHINA CORD BLOOD CORPORATION<\/p>\n

              12.9.1   OVERVIEW<\/p>\n

              12.9.2   SWOT ANALYSIS<\/p>\n

              12.9.3   PRODUCT PORTFOLIO<\/p>\n

              12.9.4   REVENUE ANALYSIS<\/p>\n

              12.9.5   ANALYSTS VIEW<\/p>\n

      12.10    CRYOVIDA<\/p>\n

              12.10.1   OVERVIEW<\/p>\n

              12.10.2   SWOT ANALYSIS<\/p>\n

              12.10.3   PRODUCT PORTFOLIO<\/p>\n

              12.10.4   REVENUE ANALYSIS<\/p>\n

              12.10.5   ANALYSTS VIEW<\/p>\n

      12.11    VIACORD<\/p>\n

              12.11.1   OVERVIEW<\/p>\n

              12.11.2   SWOT ANALYSIS<\/p>\n

              12.11.3   PRODUCT PORTFOLIO<\/p>\n

              12.11.4   REVENUE ANALYSIS<\/p>\n

              12.11.5   ANALYSTS VIEW<\/p>\n

13      APPENDIX <\/strong><\/p>\n

      13.1       RELATED REPORTS<\/p>\n

      13.2       CUSTOMIZABLE OPTIONS<\/p>\n

      13.3       SOURCE SHEET<\/p>\n

      13.3       BIBLIOGRAPHY<\/p>\n

14      ABOUT DATA BRIDGE MARKET RESEARCH <\/strong><\/p>\n

About Data Bridge Market Research:<\/strong><\/p>\n

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.<\/p>\n

Related Reports:<\/strong><\/p>\n

Global Drug Delivery Devices Market – Trends and Forecast to 2022<\/a><\/p>\n

By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022<\/p>\n

Global Self-Injections Market -Trends and Forecast to 2022<\/a><\/p>\n

By Product (Devices (Needle-Free Injectors, Auto Injectors, Pen Injectors, Wearable Injectors), Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), By Route Of Administration (Skin, Circulatory\/Musculoskeletal, Organs, Central Nervous System), By End-User (Patient, Physicians, Home Care Settings, Others), By Distribution Channel (Hospital Pharmacies, Private Clinics, Chemist, Online Pharmacies), By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, South America, Rest Of The World) – Trends and Forecast to 2022<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Data Bridge Market Research Private Limited
Contact Person:<\/strong> Shubham Dwivedi
Email:<\/strong> Sales@databridgemarketresearch.com
Phone:<\/strong> +1-888-387-2818
Address:<\/strong>Mega Center, Magarpatta City
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> http:\/\/databridgemarketresearch.com\/<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Global Cord Stem Cell Banking Market is expected to grow at 22.4% in the forecast period 2016 to 2022” Global Cord Stem Cell Banking Market, By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-89262","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/89262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=89262"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/89262\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=89262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=89262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=89262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}